I am assuming everyone here read today's story abo
Post# of 148175
(Total Views: 632)
Posted On: 05/14/2020 12:13:41 AM
I am assuming everyone here read today's story about Gilead signing a voluntary royalty-free licensing agreement with five generic drugmakers to manufacture and supply its drug Remdesivir in 127 countries.
The licensing agreement will allow the generic drugmakers to "scale up production more quickly," Gilead said, and make it accessible in countries where people face "significant obstacles to healthcare access." The companies will also get to set the prices for their own versions of the drug.
Gilead said the licenses will remain "royalty-free" until the World Health Organization has declared an end to the pandemic or until another medicine or vaccine is approved to treat or prevent the coronavirus.
The bolded text is the most interesting part of the story, and it suggests that the royalty-free provision of the agreement would sunset if leronlimab was approved. I have to assume that provision would also sunset with ANY combo drug used with remdesivir.
Big gesture on their part -- but with no real lasting value.
The licensing agreement will allow the generic drugmakers to "scale up production more quickly," Gilead said, and make it accessible in countries where people face "significant obstacles to healthcare access." The companies will also get to set the prices for their own versions of the drug.
Gilead said the licenses will remain "royalty-free" until the World Health Organization has declared an end to the pandemic or until another medicine or vaccine is approved to treat or prevent the coronavirus.
The bolded text is the most interesting part of the story, and it suggests that the royalty-free provision of the agreement would sunset if leronlimab was approved. I have to assume that provision would also sunset with ANY combo drug used with remdesivir.
Big gesture on their part -- but with no real lasting value.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼